China Orthopedic Instrument Industry Report, 2014-2017

China Orthopedic Instrument Industry Report, 2014-2017

Benefiting from accelerated aging population and rising proportion of reimbursement for medical expenses, the Chinese orthopedic instrument market demand has been effectively released, with its scale presenting a CAGR of 19.2% during 2009-2013. Trauma products, spine products and joint products are three product segments of orthopedic instruments in China, of which trauma products holding the bulk with 36.9% market share in 2013.

Being optimistic about bright future of China orthopedic instrument industry, some foreign and domestic companies are speeding up their layout in orthopedic instrument market though mergers and acquisitions. In 2012, Medtronic, Inc. acquired the most competitive orthopedic device maker in China-- China Kanghui Holdings for USD 816 million; In Jan. 2013, Stryker Corporation bought China’s largest trauma product makers-- Trauson Holdings Company Limited for HKD5.9 billion; In Sep. 2011, MicroPort Scientific Corporation entered orthopedic instrument market by purchasing Suzhou Best at transaction value of RMB 110 million, and acquired Wright's OrthoRecon business at USD 290 million in Jan. 2014.

The Chinese orthopedic instrument market now is dominated by Johnson & Johnson, Zimmer, Medtronic, Stryker and other foreign companies, together holding 40%-50% market share. However, local Chinese companies like Shandong Weigao Group Medical Polymer Co. Limited, Shanghai Kinetic Medical Co., Ltd. and United Orthopedic Corporation have made some progress in R&D and production technology in recent years, and grabbed some marker share by virtue of advantages in cost and channel.

Shandong Weigao Group Medical Polymer has become the largest local orthopedics company in China with a market share of 4.3%; Shanghai Kinetic Medical is a leader in vertebroplasty interventional operation system, occupying about 50% of the Chinese percutaneous kyphoplasty (PKP) market; United Orthopedic Corporation is a champion in artificial knee/hip joint with 4%-6% market share in China.

China Orthopedic Instrument Industry Report, 2014-2017 focuses on the following:
Development of the Chinese orthopedic instrument market, including market size, market structure, import & export, competitive landscape, barriers to entry and sales model;
Development environment of the Chinese orthopedic instrument market, covering global market environment, policy environment, macro environment, upstream and downstream sectors and development prospects;
Operation and orthopedic instrument business of 4 foreign and 14 local Chinese orthopedics companies.
1. Overview of Orthopedic Instrument Industry
1.1 Definition
1.2 Classification
1.3 Industry Chain

2. Development of Global Orthopedic Instrument Industry
2.1 Overview
2.2 Forecast

3. Development of China Orthopedic Instrument Industry
3.1 Overview
3.2 Market Structure
3.3 Import and Export
3.3.1 Import
3.3.2 Export
3.4 Competitive Landscape
3.5 Barriers to Entry
3.5.1 Technology Barrier
3.5.2 Market Access Barrier
3.5.3 Sales Channel Barrier
3.5.4 Talent Barrier
3.6 Sales Model

4. Development Environment of China Orthopedic Instrument Industry
4.1 Policy Environment
4.1.1 Regulatory Policy
4.1.2 Industrial Policy
4.2 Macro Environment
4.3 Upstream and Downstream Industries
4.3.1 Upstream Industry
4.3.2 Downstream Industry
4.4 Prospects

5. Foreign Companies in China
5.1 Johnson & Johnson
5.1.1 Profile
5.1.2 Operation
5.1.3 Revenue Structure
5.1.4 Gross Margin
5.1.5 Orthopedic Instrument Business
5.1.6 Development in China
5.2 Medtronic
5.2.1 Profile
5.2.2 Operation
5.2.3 Revenue Structure
5.2.4 Gross Margin
5.2.5 Orthopedic Instrument Business
5.2.6 Development in China
5.3 Stryker
5.3.1 Profile
5.3.2 Operation
5.3.3 Revenue Structure
5.3.4 Gross Margin
5.3.5 Development in China
5.4 Zimmer
5.4.1 Profile
5.4.2 Operation
5.4.3 Revenue Structure
5.4.4 Gross Margin
5.4.5 Orthopedic Instrument Business
5.4.6 Development in China

6. Major Chinese Companies
6.1 Shandong Weigao Group Medical Polymer
6.1.1 Profile
6.1.2 Operation
6.1.3 Revenue Structure
6.1.4 Gross Margin
6.1.5 Orthopedic Instrument Business
6.1.6 R&D and Investment
6.1.7 Customers
6.1.8 Forecast and Outlook
6.2 Shanghai Kinetic Medical
6.2.1 Profile
6.2.2 Operation
6.2.3 Revenue Structure
6.2.4 Gross Margin
6.2.5 R&D and Investment
6.2.6 Forecast and Outlook
6.3 United Orthopedic Corporation
6.3.1 Profile
6.3.2 Operation
6.3.3 Revenue Structure
6.3.4 Gross Margin
6.3.5 R&D and Investment
6.3.6 Forecast and Outlook
6.4 Beijing AKEC Medical
6.4.1 Profile
6.4.2 Operation
6.4.3 Revenue Structure
6.4.4 Gross Margin
6.4.5 R&D and Investment
6.4.6 Capacity, Output and Sales Volume
6.4.7 Customers and Suppliers
6.5 Suzou Xinrong Best Medical Instrument
6.5.1 Profile
6.5.2 Operation
6.5.3 Orthopedic Instrument Business
6.6 Tianjin Walkman Biomaterial
6.6.1 Profile
6.6.2 Operation
6.6.3 Orthopedic Instrument Business
6.7 Beijing Lidakang Science and Technology
6.7.1 Profile
6.7.2 Operation
6.7.3 Orthopedic Instrument Business
6.8 Tianjin Renli Orthopedic Instrument
6.8.1 Profile
6.8.2 Operation
6.9 Zhejiang Guangci Medical Device
6.9.1 Profile
6.9.2 Orthopedic Instrument Business
6.10 Suzhou AND Science & Technology Development
6.10.1 Profile
6.10.2 Orthopedic Instrument Business
6.11 Beijing Chunlizhengda Technology & Development
6.11.1 Profile
6.11.2 Orthopedic Instrument Business
6.12 Baimtec Material
6.12.1 Profile
6.12.2 Orthopedic Instrument Business
6.13 Suzhou Kangli Orthopedics Instrument
6.13.1 Profile
6.13.2 Orthopedic Instrument Business
6.14 Waston Medical Appliance
6.14.1 Profile
6.14.2 Orthopedic Instrument Business

7. Forecast and Outlook
7.1 Market Size Forecast
7.2 Operation Comparison of Major Companies
7.2.1 Revenue
7.2.2 Net Income
7.2.3 Gross Margin
7.2.4 Orthopedic Instrument Business